Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000074

EVP, Chief Development Officer sold 7,338 shares at $50.42 ($369,960)

  • EVP, Chief Development Officer acquired 19,852 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-16 Exercise or conversion : show line 1 in the form +19,852 92,813 D
2024-01-17 Sale : show line 2 in the form −7,338 $50.42 $369,960 85,475 D
Open-market sales · 7,338 sh · avg $50.42 · $369,960

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2024-01-16 Exercise or conversion : show line 3 in the form Restricted Stock Unit −19,852 $0.00 19,852 46,625 D
Loading xslF345X05/edgardoc.xml…